A Twenty-years' Experience in Pituitary Disease.

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS

About this trial

Pituitary tumors represent a heterogeneous group of neoplasms by histotype. The pituitary adenomas are the most frequent heteroformation, among those affecting the pituitary gland, followed by meningiomas, craniopharyngiomas, germosomes and tumours secondary, such as metastases and lymphomas. Since these conditions are considered rare, the data epidemiology and prognosis to predict the natural history of these diseases can not be considered conclusive. Pituitary adenomas are a useful model for epidemiology in the study of pathology pituitary. Over the past 20 years, several attempts have been made to identify unique prognostic factors, which predict the outcome of these pathologies, but without To arrive at a definitive classification. The purpose of this study aims to collect clinical, biochemical, morphological and pathological data on the retrospective and prospective cohort of over 1600 patients undergoing neurosurgical removal of pituitary tumors in the last 20 years, to develop a prognostic classification.

Eligibility criteria

Qualifiers

Patients underwent surgery for pituitary tumors;

pathology diagnosis of pituitary tumors;

patients older then 18 years at diagnosis of pituitary tumors;

2 years follow-up;

Disqualifiers

age lower then 18 years

follow-up shorter than 2 years

Trial design

Treatments tested in this trial

  • Frequency of disease recurrence

Treatment groups

1,600 Participants
are divided into 1 treatment group